|Articles|January 15, 2002
- BioPharm International-01-01-2002
- Volume 15
- Issue 1
Inside Washington: Biotechnology in the Limelight, the Year Ahead
Author(s)Jill Wechsler
by Jill Wechsler Continued concerns about bioterrorism will shape legislative and regulatory initiatives affecting biotech manufactures.
Advertisement
Articles in this issue
almost 24 years ago
Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaborationalmost 24 years ago
Your Vested Interests: The War of the Westalmost 24 years ago
Statistics for Laboratory Method Comparison Studiesalmost 24 years ago
From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continuesalmost 24 years ago
Liposomes (a Review): Part Two, Drug Delivery Systemsalmost 24 years ago
Information Age AuditsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Challenges, Innovations, and Future Outlook of Biologics Formulations
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
